Citation: H. Huland, WHAT IMPORTANCE DOES RADICAL PROSTATECTOM Y HAVE IN LYMPH-NODE POSITIVE CANCER OF THE PROSTATE, Der Urologe, 37(2), 1998, pp. 138-140
Authors:
NOLDUS J
GRAEFEN M
HAMMERER P
HENKE RP
HULAND H
Citation: J. Noldus et al., DEVELOPMENT OF TUMOR SELECTION ON THE BAS IS OF PATHOLOGICAL STAGING IN CLINICALLY LOCALIZED PROSTATE CARCINOMA, Der Urologe, 37(2), 1998, pp. 195-198
Authors:
LANGE I
HAMMERER P
KNABBE C
GRAEFEN M
SCHMAHL M
HULAND H
Citation: I. Lange et al., TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BE TA-1) LEVELS IN PLASMA OF PATIENTS WITH PROSTATE-CANCER AND BENIGN PROSTATIC HYPERPLASIA (BPH), Der Urologe, 37(2), 1998, pp. 199-202
Citation: H. Heinzer et al., THROMBOEMBOLIC COMPLICATION RATE AFTER RADICAL RETROPUBIC PROSTATECTOMY - IMPACT OF ROUTINE ULTRASONOGRAPHY FOR THE DETECTION OF PELVIC LYMPHOCELES AND HEMATOMAS, European urology, 33(1), 1998, pp. 86-90
Authors:
GRAEFEN M
HAMMERER P
MICHL U
NOLDUS J
HAESE A
HENKE RP
HULAND E
HULAND H
Citation: M. Graefen et al., INCIDENCE OF POSITIVE SURGICAL MARGINS AFTER BIOPSY-SELECTED NERVE-SPARING RADICAL PROSTATECTOMY, Urology, 51(3), 1998, pp. 437-442
Citation: H. Huland, FREE AND COMPLEXED PROSTATE-SPECIFIC ANTIGEN IN THE DIFFERENTIATION OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE-CANCER - STUDIES IN SERUM AND PLASMA SAMPLES - EDITORIAL COMMENT, The Journal of urology, 160(6), 1998, pp. 2088-2088
Authors:
SCHWAIBOLD H
FRIEDRICH MG
FERNANDEZ S
CONRAD S
HULAND H
Citation: H. Schwaibold et al., IMPROVEMENT OF URETEROILEAL ANASTOMOSIS IN CONTINENT URINARY-DIVERSION WITH MODIFIED LE DUC PROCEDURE, The Journal of urology, 160(3), 1998, pp. 718-720
Authors:
NOLDUS J
GRAEFEN M
HULAND E
BUSCH C
HAMMERER P
HULAND H
Citation: J. Noldus et al., THE VALUE OF THE RATIO OF FREE-TO-TOTAL PROSTATE-SPECIFIC ANTIGEN FORSTAGING PURPOSES IN PREVIOUSLY UNTREATED PROSTATE-CANCER, The Journal of urology, 159(6), 1998, pp. 2004-2007
Authors:
CONRAD S
GRAEFEN M
PICHLMEIER U
HENKE RP
HAMMERER PG
HULAND H
Citation: S. Conrad et al., SYSTEMATIC SEXTANT BIOPSIES IMPROVE PREOPERATIVE PREDICTION OF PELVICLYMPH-NODE METASTASES IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATIC-CARCINOMA, The Journal of urology, 159(6), 1998, pp. 2023-2029
Authors:
LILJA H
HULAND E
HAESE A
FRIEDRICH M
HULAND H
PETTERSSON K
PIIRONEN T
Citation: H. Lilja et al., ELIMINATION OF COMPLEXED AND NON-COMPLEXED PROSTATE-SPECIFIC ANTIGEN FORMS (PSA) AND HUMAN GLANDULAR KALLIKREIN 2 (HK2) FOLLOWING RADICAL PROSTATECTOMY (RP), The Journal of urology, 159(5), 1998, pp. 270-270
Authors:
HAMMERER P
HENKE RP
ERBERSDOBLER A
SCHWAIBOLD H
GRAEFEN M
HULAND H
Citation: P. Hammerer et al., SPECIFIC PATTERN OF VASCULARIZATION IN THE DIFFERENT ZONES OF THE PROSTATE, The Journal of urology, 159(5), 1998, pp. 422-422
Authors:
HAESE A
HULAND E
GRAEFEN M
HAMMERER P
HULAND H
Citation: A. Haese et al., LONG-TERM FOLLOW-UP (UP TO 2057 DAYS) OF 423 PATIENTS AFTER RADICAL PROSTATECTOMY (RP) BY ULTRASENSITIVE PSA DETECTION PSA-FREE SURVIVAL AND HISTOPATHOLOGY, The Journal of urology, 159(5), 1998, pp. 696-696
Authors:
FRIEDRICH M
ERBERSDOBLER A
SCHWAIBOLD H
HULAND E
HULAND H
Citation: M. Friedrich et al., DETECTION OF LOSS OF HETEROZYGOSITY (LOH) IN THE P53-GENE AMONG BLADDER-CANCER PATIENTS IN TUMOR AND URINARY SEDIMENT USING A SIMPLE POLYMERASE-CHAIN-REACTION (PCR) TECHNIQUE, The Journal of urology, 159(5), 1998, pp. 1078-1078
Citation: H. Huland, IMMUNOSTAINING OF LEWIS-X IN CELLS FROM VOIDED URINE, CYTOPATHOLOGY AND ULTRASOUND FOR NONINVASIVE DETECTION OF BLADDER-TUMORS - COMMENT, The Journal of urology, 159(2), 1998, pp. 393-393
Authors:
HENKE RP
HAMMERER P
GRAEFEN M
ERBERSDOBLER A
NEUMANN M
BERGER J
HULAND H
Citation: Rp. Henke et al., INTERPHASE CYTOGENETIC STUDY OF PREOPERATIVE CORE BIOPSIES FOR THE PREDICTION OF EARLY SERUM PROSTATE-SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY OF CLINICALLY LOCALIZED PROSTATE CARCINOMA, Cancer, 83(5), 1998, pp. 977-988
Citation: S. Conrad et H. Huland, CYSTITIS THERAPY WITH IMMUNOMODULATING ES CHERICHIA-COLI FRACTIONS, Deutsche Medizinische Wochenschrift, 122(14), 1997, pp. 460-460
Citation: E. Huland et al., INHALED INTERLEUKIN-2 THERAPY IN PULMONARY METASTATIC RENAL-CELL CARCINOMA - 6 YEARS OF EXPERIENCE, The cancer journal from Scientific American, 3, 1997, pp. 98-105
Citation: H. Schwaibold et al., IMMUNOCYTOLOGIC STAINING OF CYTOKERATIN IN BONE-MARROW ASPIRATES TO DETECT MICROMETASTATIC CELLS FAILS IN PATIENTS WITH METASTATIC UROLOGICCARCINOMA, International journal of oncology, 11(6), 1997, pp. 1197-1201
Citation: S. Hautmann et al., LOCAL INTRATUMORAL IMMUNOTHERAPY OF PROSTATE-CANCER WITH INTERLEUKIN-2 REDUCES TUMOR-GROWTH SIGNIFICANTLY, European journal of cancer, 33, 1997, pp. 134-134
Citation: E. Huland et al., 6 YEARS EXPERIENCE USING INHALATORY INTERLEUKIN-2 IN PULMONARY METASTATIC RENAL-CELL CARCINOMA, European journal of cancer, 33, 1997, pp. 373-373